Cargando…
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results
BACKGROUND: To report toxicity and early clinical outcomes of hypofractionated simultaneous integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant treatment after breast-conserving surgery. METHODS: Patients presenting early-stage breast cancer were enrolled in a ph...
Autores principales: | De Rose, Fiorenza, Fogliata, Antonella, Franceschini, Davide, Navarria, Piera, Villa, Elisa, Iftode, Cristina, D’Agostino, Giuseppe, Cozzi, Luca, Lobefalo, Francesca, Mancosu, Pietro, Tomatis, Stefano, Scorsetti, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027088/ https://www.ncbi.nlm.nih.gov/pubmed/27639373 http://dx.doi.org/10.1186/s13014-016-0701-z |
Ejemplares similares
-
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy
por: Franzese, Ciro, et al.
Publicado: (2015) -
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study
por: Alongi, Filippo, et al.
Publicado: (2013) -
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery
por: Franzese, Ciro, et al.
Publicado: (2017) -
In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study
por: Mancosu, Pietro, et al.
Publicado: (2015) -
MLC parameters from static fields to VMAT plans: an evaluation in a RT-dedicated MC environment (PRIMO)
por: Paganini, Lucia, et al.
Publicado: (2019)